We are very happy that we will again have two great speakers to introduce the topic:
- Markwin Velders, VP Operations and Managing Director at Kite Pharma EU, will give us an introduction on the personalised cancer treatments that Kite is working on, and on how this has been received by care markets.
- Marc van Kempen, VP of Development at Teva Pharmaceuticals, will present pharma’s efforts in building data driven patient solutions, and how they contribute to personalised treatment.
In the ensuing debate, we hope to hear your ideas and opinions. As an attendee, you are invited to actively join the discussion.
Hope to see you at Café Polder. This location offers an attractive, informal atmosphere, but spaces are limited, so do not wait too long to register. The Amsterdam Life Sciences Café is free of charge.